NCT06324071View on ClinicalTrials.gov

Study to Verify the Efficacy of a Product Containing 125 mg of TetraSOD® for the Treatment of Male Infertility

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Male Infertility
Interventions
DIETARY_SUPPLEMENT

Sham

Participants in the Control group will receive a daily dose of placebo in a capsule during 90 days.

DIETARY_SUPPLEMENT

Marine microalgae Tetraselmis chuii with high Superoxide Dismutase (SOD) activity

Participants in the Experimental group will receive a daily dose of 125 mg of TetraSOD® in a capsule during 90 days.

Trial Locations (1)

08036

RECRUITING

Hospital Clinic, Barcelona

Sponsors

Collaborators (1)

Fertypharm
All Listed Sponsors
collaborator

Fundacio Clinic Barcelona

OTHER

collaborator

Fertypharm

INDUSTRY

lead

Fitoplancton Marino, S.L.

INDUSTRY